Organizer: Kyeong Hye Park (National Health Insurance Service Ilsan Hospital)

Organizer: Kyeong Hye PARK (National Health Insurance Service Ilsan Hospital)
Management of chronic diseases will become more important in the upcoming super-aged society. This is because chronic diseases such as osteoporosis and diabetes are the most commonly occurring diseases among endocrine diseases. Of course, the medical staffs in the endocrinology department are obliged to take a proactive interest in the elderly medicine. Accordingly, the insurance committee intends to actively prepare for the future of endocrinology medicine through the training experience of Kim Chul-joong, Korea’s leading medical journalist, in Japan.

Organizer: Sang Ouk CHIN (Kyung Hee University)
Through this session, you will learn effective method of accurately diagnosing Cushing Syndrome caused by various causes. Additionally, the endocrine physicians have prepared lectures on the latest information on gastrointestinal neuroendocrine tumors. Finally, we will have time to learn about the recently revised guidelines for treating acromegaly.

Organizer: Kyoung Min KIM (Yonsei University)
Due to the rapid aging of society in recent years, the period to treat osteoporosis and prevent fractures after menopause or due to aging has been extended. This is being said to be a very challenging part for the medical staff treating osteoporosis. Fortunately, new drugs are being introduced recently and used for the treatment of osteoporosis, and various drugs can be selected according to the individual's fracture risk. However, despite the development of powerful new anti-osteoporotic agents, the importance of osteoporosis drugs introduced in the past is being newly emphasized. Therefore, in this Clinical Update session, three speakers will give a lecture on the clinical use of osteoporosis drugs in the past with the subject of “History Repeats Itself! [溫故知新]”. Firstly, Professor Yong Jun CHOI of Aju University will introduce the efficacy and value of Active Vitamin D in the field of osteoporosis treatment with a title of “The Efficacy of Active Vitamin D Therapy in the Management of Bone Loss and Fractures”. Secondly, Professor Seong Hee AHN of Inha University will provide a lecture with a title of “Older, but Newer Roles of Bisphosphonate”. While the use of Bisphosphonate has decreased somewhat since the recent release of new drugs Denosumab and Romosozumab, its importance is still being emphasized in the sequential treatment of osteoporosis. In this lecture, Professor Seong Hee AHN will give a lecture on the role of bisphosphonates in the sequential treatment of osteoporosis. The third and final topic is about SERM, and Professor Yun Kyung JEON of Busan National University Hospital prepared a lecture titled “Re-visit of SERM in new era of aging society”. As SERM is also a drug that has been widely used as an osteoporosis drug in the past, and its importance in the long-term osteoporosis treatment concept and safety has been re-emerging, Professor Yun Kyung JEON will re-examine the value of SERM drugs.

Organizer: Kyu Yeon HUR (Sungkyunkwan University)
The biggest key and change in this guideline is that the drug treatment for type 2 diabetes is clearly divided into the cases where the drug must be selected with a focus on glycemic control and the case where the drug must be selected in consideration of associated diseases. Recently, the release of drugs that have proven the benefits of certain agents when cardiovascular disease is accompanied has caused many cases of misunderstanding as if all diabetic patients must use these drugs first, causing confusion in the medical field.
Based on the results of clinical studies so far, it was recommended separately whether to select the drug based on blood glucose or to select the drug in consideration of comorbidity according to the patient. Therefore, we tried to divide the algorithm into 4 categories, making them more subdivided. First, we emphasized the importance of setting a target blood glucose that suits each individual situation. This is because the combination and intensity of drug therapy should be determined based on the target blood glucose and current blood glucose situation at any time. Algorithms 1, 2, and 3 represent drug selection based on blood glucose, and Algorithm 4 represents drug selection considering comorbidities.

There are 9 types of diabetes drugs in their class alone with quite a large number of individual drugs in each class, and there are cases where there are differences in drug action time or indications between individual drugs. In addition, the drug approval and reimbursement standards are different for each drug rather than a class, and even these standards are continuously updated in a short period of time, burdening the difficulties in actual clinical practice. The Web-based Clinical Decision Supporting System (CDSS) was developed by the Korean Diabetes Association's guideline committee and the information committee to help a little bit about the difficulties of drug selection in the clinical setting. In this session, although it is still in its early stage, I would like to briefly introduce the CDSS, which was developed for the first time by domestic and foreign conferences.

Organizer: Sun Wook CHO (Seoul National University)
In this session, we would like to introduce you to the latest updates in the diagnosis and treatment of thyroid disease. The Korean thyroid imaging reporting and data system (K-TIRADS) system, which is the standard for ultrasound diagnosis of thyroid nodules, is being prepared for revision. In this session, we would like to invite Professor Ji Hoon KIM of the Korean Society of Thyroid Radiology (Seoul University of Medicine, Department of Radiology) to hear the latest knowledge. Afterwards, the following two lectures will invite Professor Eun Kyung LEE of the National Cancer Center and Professor Ji Min HAN of Samsung Changwon Hospital, who are active in clinical practice, and learn about the study findings of the various studies conducted in 2020-2021 and the latest knowledge on the fields of diagnosis and treatment of thyroid nodules and cancer, and thyroid function diseases, accordingly.